Ignota Labs has harvested more assets for its drug candidate rehabilitation scheme, snapping up Kronos Bio’s clinical pipeline months after a series of setbacks drove the biotech off public markets. U ...

New to N.I.N.A.? In this beginner-friendly tutorial, I walk you through setting up your first sequence from scratch using the powerful N.I.N.A. sequencer. Perfect for automating your imaging session ...

Instead of just including a library of pre-recorded samples captured from percussion instruments like marimbas and xylophones, Korg Berlin’s Phase8 features eight “replaceable and tunable metal ...

Kronos Bio is vacating its corporate headquarters amid a wider cost-cutting exercise for the struggling biotech. The company, which has been focused on developing small-molecule drugs for cancers and ...

Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...

NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

Kronos Worldwide, Inc. KRO recently announced that it acquired a 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”). It was previously held by Venator Investments, Ltd. Kronos, ...

Nearly two years after the Kronos Private Cloud platform outage, its fallout continues to settle — and Cargill is just one of many employers facing litigation over their handling of the incident.